Free Newsletter
WHO suspends Indian vax purchases as it probes quality
Perplexed by the appearance of mysterious white sediment inside vials of vaccine produced by an Indian subsidiary of Sanofi-Aventis, the World Health Organization has suspended the purchase and distribution of its Shan5 jab. According to Sanofi, the move comes as a "precautionary measure pending outcome of an investigation of vaccine quality."
A spokesperson for the WHO insists that there have been no safety problems yet discovered with the vaccine, a shot that provides protection against diphtheria, pertussis, tetanus, Haemophilus influenza B, and hepatitis B. However, even after vigorous shaking, the sediment was hard to disperse. And that, she adds, is a rare problem.
India's Shantha Biotechnics landed a contract valued at $340 million last fall to supply the vaccine to the WHO through 2012--just months after Sanofi bought it.
- here's the Wall Street Journal report
Related Articles:
Sanofi to donate 100M doses of new flu vaccine
Mass vaccination program could target schools
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: